| Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis KL Stirrett, JA Ferreras, V Jayaprakash, BN Sinha, T Ren, LEN Quadri Bioorganic & medicinal chemistry letters 18 (8), 2662-2668, 2008 | 92 | 2008 |
| Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies A Sahoo, S Yabanoglu, BN Sinha, G Ucar, A Basu, V Jayaprakash Bioorganic & medicinal chemistry letters 20 (1), 132-136, 2010 | 86 | 2010 |
| Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads S Vadivelan, BN Sinha, G Rambabu, K Boppana, SARP Jagarlapudi Journal of Molecular Graphics and Modelling 26 (6), 935-946, 2008 | 85 | 2008 |
| Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity B Chetan, M Bunha, M Jagrat, BN Sinha, P Saiko, G Graser, T Szekeres, ... Bioorganic & medicinal chemistry letters 20 (13), 3906-3910, 2010 | 76 | 2010 |
| Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis VN Badavath, I Baysal, G Ucar, BN Sinha, V Jayaprakash ACS Medicinal Chemistry Letters 7 (1), 56-61, 2016 | 70 | 2016 |
| Virtual screening studies to design potent CDK2-cyclin A inhibitors S Vadivelan, BN Sinha, SJ Irudayam, SARP Jagarlapudi Journal of chemical information and modeling 47 (4), 1526-1535, 2007 | 70 | 2007 |
| Thiazolidone derivatives as inhibitors of chikungunya virus SS Jadav, BN Sinha, R Hilgenfeld, B Pastorino, X De Lamballerie, ... European Journal of Medicinal Chemistry 89, 172-178, 2015 | 69 | 2015 |
| Monoamine oxidase inhibitory activity of 3, 5-biaryl-4, 5-dihydro-1H-pyrazole-1-carboxylate derivatives BV Nayak, S Ciftci-Yabanoglu, SS Jadav, M Jagrat, BN Sinha, G Ucar, ... European journal of medicinal chemistry 69, 762-767, 2013 | 69 | 2013 |
| Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies M Karuppasamy, M Mahapatra, S Yabanoglu, G Ucar, BN Sinha, A Basu, ... Bioorganic & medicinal chemistry 18 (5), 1875-1881, 2010 | 68 | 2010 |
| Pyrazoline-based mycobactin analogues as MAO-inhibitors V Jayaprakash, BN Sinha, G Ucar, A Ercan Bioorganic & medicinal chemistry letters 18 (24), 6362-6368, 2008 | 65 | 2008 |
| Progress and prospects on DENV protease inhibitors AK Timiri, BN Sinha, V Jayaprakash European journal of medicinal chemistry 117, 125-143, 2016 | 55 | 2016 |
| Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones VN Badavath, S Ciftci-Yabanoglu, S Bhakat, AK Timiri, BN Sinha, G Ucar, ... Bioorganic chemistry 58, 72-80, 2015 | 54 | 2015 |
| Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies M Jagrat, J Behera, S Yabanoglu, A Ercan, G Ucar, BN Sinha, V Sankaran, ... Bioorganic & medicinal chemistry letters 21 (14), 4296-4300, 2011 | 54 | 2011 |
| Determining the antioxidant activity of certain medicinal plants of Attapady,(Palakkad), India using DPPH assay. KR Sini, BN Sinha, M Karpagavalli | 53 | 2010 |
| Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors SS Jadav, S Kaptein, A Timiri, T De Burghgraeve, VN Badavath, ... Bioorganic & medicinal chemistry letters 25 (8), 1747-1752, 2015 | 51 | 2015 |
| A novel druggable interprotomer pocket in the capsid of rhino-and enteroviruses R Abdelnabi, JA Geraets, Y Ma, C Mirabelli, JW Flatt, A Domanska, ... PLoS Biology 17 (6), e3000281, 2019 | 47 | 2019 |
| Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors AK Timiri, S Selvarasu, M Kesherwani, V Vijayan, BN Sinha, ... Bioorganic chemistry 62, 74-82, 2015 | 46 | 2015 |
| Quinazoline derivatives as selective CYP1B1 inhibitors MUM Siddique, GJP McCann, VR Sonawane, N Horley, L Gatchie, ... European journal of medicinal chemistry 130, 320-327, 2017 | 44 | 2017 |
| Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro V Cagno, A Civra, R Kumar, S Pradhan, M Donalisio, BN Sinha, M Ghosh, ... Journal of ethnopharmacology 176, 252-257, 2015 | 43 | 2015 |
| The Mycobactin biosynthesis pathway: A prospective therapeutic target in the battle against tuberculosis M Shyam, D Shilkar, H Verma, A Dev, BN Sinha, F Brucoli, S Bhakta, ... Journal of Medicinal Chemistry 64 (1), 71-100, 2020 | 42 | 2020 |
